Skip to main content

Table 2 Functional outcome measures and post hoc test results

From: Does minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) influence functional outcomes and spinopelvic parameters in isthmic spondylolisthesis?

 

Baseline

Postoperative

Test*

p value (Sig.)

6 weeks

6 months

Final

Visual Analogue Scale (VAS) for back

Mean ± SD

8.42 ± 0.58

3.58 ± 0.65

2.17 ± 0.38

1.79 ± 0.88

62.074*

< 0.001 (HS)

Median (range)

8 (7–9)

3.5 (3–5)

2 (2–3)

1.5 (1–3)

Visual Analogue Scale (VAS) for leg

Mean ± SD

7.46 ± 0.98

3.33 ± 0.48

1.25 ± 0.44

1.00 ± 1.59

66.792*

< 0.001 (HS)

Median (range)

7 (6–9)

3 (3–4)

1 (1–2)

1 (0–8)

Oswestry Disability Index (ODI)%

Mean ± SD

52.21 ± 6.79

17.54 ± 1.25

14.04 ± 2.35

15.71 ± 9.95

59.484*

< 0.001 (HS)

Median (range)

51 (42–63)

18 (15–19)

14 (10–19)

14.5 (10–61)

Post hoc test results

 

Preoperative versus 6 weeks

Preoperative versus 6 months

Preoperative versus final

6 weeks versus 6 months

6 weeks versus final

6 months versus final

Visual Analogue Scale (VAS) for back

Test‡

− 4.451

− 4.373

− 4.323

− 4.092

− 4.011

− 1.806

p value (Sig.)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

< 0.001(HS)

0.071

Visual Analogue Scale (VAS) for Leg

Test‡

− 4.344

− 4.328

− 4.319

− 4.518

− 3.7

− 2.337

p value (Sig.)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

0.019

Oswestry Disability Index (ODI)

Test‡

− 4.289

− 4.29

− 4.26

− 3.75

− 3.189

− 0.241

p value (Sig.)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

< 0.001 (HS)

0.001 (S)

0.809

  1. *Friedman’s test was used, ‡ Wilcoxon signed-rank test, p < 0.05 is significant and Sig.: Significance